All lobbying filings

CAPITOL COUNSEL LLC

Lobbying for LUNDBECK PHARMACEUTICALS LLC · Specialty and Central Nervous System Bio-pharmaceutical manufacturing.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Illinois · House · Senate · $40,000.00 income · posted Jul 16, 2026

Official filing document

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 2

Health Issues

Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA.

Medicare/Medicaid

Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.